Suministro sucesivo del anticuerpo monoclonal frente al virus sincitial respiratorio, NIRSEVIMAB (Beyfortus®)
TED · 587902-2026Voluntary ex-ante transparency noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Consellería de Sanidade in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| GLAXOSMITHKLINE, S.A. | 2 | €18,938,500 | 2026-09-22 |
| PALEX MEDICAL, S.A | 2 | €2,730,000 | 2026-09-09 |
| SANOFI-AVENTIS, S.A. | 1 | €8,990,800 | 2026-08-13 |
| PFIZER S. L.U | 1 | €5,185,400 | 2026-09-02 |
| ROCHE DIAGNOSTICS, S.L.U. | 1 | €2,138,400 | 2026-09-17 |
Full buyer profile: what Consellería de Sanidade buys and who wins it →
CPV codes
33690000 Medical equipment & pharmaceuticalsDescription
Suministro sucesivo del anticuerpo monoclonal frente al virus sincitial respiratorio, NIRSEVIMAB (Beyfortus®)
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-08 | Suministro sucesivo de la vacuna frente a la Hepatitis A+B (TWINRIX ADULTO) | Consellería de Sanidad ES | 92% |
| 2026-06-29 | Suministro de medicamentos exclusivos Bimekizumab para el Consorci Sanitari de l'Anoia | Consorci Sanitari de l'Anoia ES | 91% |
| 2026-06-30 | Suministro de la vacuna frente al virus respiratorio sincitial Arexvy exclusiva del laboratorio farmacéutico Glaxosmithkline, s.a | Servicio Murciano de Salud - Junta de Compras ES | 91% |
| 2026-06-04 | Suministro de Risankizumab (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 91% |
| 2026-07-13 | Vacuna antigripal trivalente inactivada de alta carga producida a partir de virus crecidos en huevos embrionados | Servicio Murciano de Salud - Junta de Compras ES | 90% |
| 2026-09-03 | Suministro de Emicizumab (DOE) y Risdiplam (DOE) | OSAKIDETZA - Servicio Vasco de Salud - Organización Central ES | 90% |